County
Chelan/Douglas/Okanogan/Grant County
Chelan/Douglas/Okanogan/Grant County (WA) carries 42 drugs across 139 dose entries in its current published protocol, effective 2025-05-01.
Drugs and doses42
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV | not captured | standing | page 222 |
| Fever | adult | 650 mg | PO | not captured | standing | page 222 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 222 |
| Fever | peds | 15 mg/kg | IV | not captured | standing | page 222 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 222 |
| Mild to moderate pain | adult | 650 mg | PO | not captured | standing | page 222 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 222 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 222 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 224 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 224 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 225 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 225 |
| Hyperkalemia | adult | 2.5 mg | NEB | not captured | standing | page 225 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | page 225 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 226 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 226 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 223 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV/IO | not captured | standing | page 228 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 228 |
| Organophosphate poisoning | adult | 2 mg | IV | not captured | standing | page 228 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV | not captured | standing | page 228 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 229 |
Buprenorphine-Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 35 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 10–20 mL | IV/IO | not captured | standing | page 50 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 10–20 mL | IV/IO | not captured | standing | page 50 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 50 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 50 |
| Hyperkalemia | adult | 1–2 g | IV/IO | not captured | standing | page 50 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 50 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 25–50 g | IV/IO | not captured | standing | page 50 |
| Cardiac arrest | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 50 |
| Hypoglycemia | adult | 25–50 g | IV/IO | not captured | standing | page 45 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 45 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg | IV | not captured | standing | page 29 |
| Procedural sedation | adult | 5–10 mg | IV | not captured | standing | page 233 |
| Seizure | adult | 5–10 mg | IV | not captured | standing | page 29 |
| Seizure | peds | 0.1–0.2 mg/kg | IV | not captured | standing | page 29 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 179 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 71 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 29 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 29 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 29 |
| Dystonic reaction | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 29 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 5–20 mcg/kg | IV | not captured | standing | page 236 |
| Cardiogenic shock | peds | 5–20 mcg/kg | IV | not captured | standing | page 236 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV | not captured | standing | page 236 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV | not captured | standing | page 236 |
| Sepsis | adult | 5–20 mcg/kg | IV | not captured | standing | page 236 |
| Sepsis | peds | 5–20 mcg/kg | IV | not captured | standing | page 236 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 29 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 29 |
| Asthma / bronchospasm | peds | 1 mL/kg | NEB | not captured | standing | page 167 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 65 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 65 |
| Stridor | peds | 1 mL/kg | NEB | not captured | standing | page 167 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.2–0.3 mg/kg | IV | not captured | standing | page 8 |
| RSI induction | peds | 0.2–0.3 mg/kg | IV | not captured | standing | page 8 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–1.5 mcg/kg | IV/IM/IN | not captured | standing | page 18 |
| Mild to moderate pain | peds | 1–1.5 mcg/kg | IV/IM/IN | not captured | standing | page 18 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20 mg | IV | not captured | standing | page 241 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 241 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–2 mg | IV | not captured | standing | page 242 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 5–10 mg | IV | not captured | standing | page 242 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 242 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 45 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM | not captured | standing | page 29 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.01 mg/kg | IV/IM | not captured | standing | page 18 |
| Mild to moderate pain | peds | 0.01 mg/kg | IV/IM | not captured | standing | page 18 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 245 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | page 245 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 171 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 171 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 171 |
| COPD | peds | 0.25 mg | NEB | not captured | standing | page 171 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–4 mg/kg | IM/IN | not captured | standing | page 29 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO | not captured | standing | page 8 |
| Post-intubation sedation | peds | 1 mg/kg | IV/IO | not captured | standing | page 8 |
| RSI induction | adult | 1–2 mg/kg | IV/IO | not captured | standing | page 8 |
| RSI induction | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 8 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 20 mg | IV | not captured | standing | page 105 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 249 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 65 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 65 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–2 mg | IV | not captured | standing | page 251 |
| Procedural sedation | adult | 2 mg | IV | not captured | standing | page 251 |
| Procedural sedation | peds | 0.05 mg/kg | IV | not captured | standing | page 251 |
| Seizure | adult | 2–4 mg | IV | not captured | standing | page 251 |
| Seizure | peds | 0.05–0.1 mg/kg | IV | not captured | standing | page 251 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| COPD | adult | 2 g | IV | not captured | standing | page 252 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV | not captured | standing | page 105 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 105 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | page 252 |
| Wide-complex tachycardia | peds | 25–50 mg/kg | IV | not captured | standing | page 252 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 33 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 33 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 43 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | page 43 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IV/IM/IN | not captured | standing | page 29 |
| Agitation | peds | 0.05–0.1 mg/kg | IV/IM/IN | not captured | standing | page 29 |
| Post-intubation sedation | adult | 2–5 mg | IV/IM | not captured | standing | page 8 |
| Post-intubation sedation | peds | 0.05–0.1 mg/kg | IV/IM | not captured | standing | page 8 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | page 52 |
| Seizure | adult | 5 mg | IV | not captured | standing | page 52 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 52 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 52 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IM | not captured | standing | page 18 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 18 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4 mg | IV/IO/IM | not captured | standing | page 31 |
| Opioid overdose | adult | 0.4 mg | IN | not captured | standing | page 31 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 31 |
| Opioid overdose | peds | 0.2 mg/kg | IN | not captured | standing | page 31 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 37 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–36 mcg | IV | not captured | standing | page 51 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV | not captured | standing | page 51 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 18 |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 18 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 18 |
| Nausea / vomiting | peds | 2 mg | ODT | not captured | standing | page 18 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25 mg | IM | not captured | standing | page 18 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.2 mg/kg | IV/IO | not captured | standing | page 8 |
| RSI induction | peds | 1.2 mg/kg | IV/IO | not captured | standing | page 8 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 65 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 65 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 50 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 50 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 50 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 50 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 8 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 8 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2-4 gtt | not captured | not captured | standing | page 89 |
| Other | peds | 2-4 gtt | not captured | not captured | standing | page 89 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV | not captured | standing | page 111 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 99 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg | IV | not captured | standing | page 24 |
| Agitation | peds | 0.1 mg/kg | IV | not captured | standing | page 24 |